Quofenix 300 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - 10 x 300 mg Swissmedic Key 67239001 Registration Holder A. Menarini GmbH Name Quofenix 300 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Date of registration 28.05.2020 Introduction of Sequence 28.05.2020 ATC-Classification Delafloxacin (J01MA23) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.01.80. Show package size 10 x 300 mg Index Therapeuticus (Swissmedic) 08.01.80. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 684.95 Limitation Yes Limitation text
Deductible 10 % Consumer price 761.35 Feedback FB GTIN 7680672390017 Medication Code Synthetika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: delafloxacinum 300 mg ut delafloxacinum megluminum, megluminum, sulfobutylbetadexum natricum 2.4 g, dinatrii edetas, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium 175 mg. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Excipiens BAG: Active Agent Dose 300 mg
Inactive agents Dose Meglumine Sodium Hydroxide 2.4 g
Source Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
